Document ID: chunk:federal_register_of_legislation:F2006L02853:body:0:p8
Version: federal_register_of_legislation:F2006L02853
Segment Type: other
Provision Reference: 
Character Range: 20852–22465

of the program, and provide comment on the operations of these Directions.

PART 7 – REVOCATION OF EARLIER DIRECTIONS

   17.  The Pharmaceuticals Partnerships Program Directions No 1 of 2003 and the Pharmaceuticals Partnerships Program Directions No 1 of 2004 are revoked.

PART 8 – TRANSITIONAL PROVISIONS

   18.    The revoked directions, as in force immediately before the commencement of these Directions, continue to apply in relation to assessments made by the Board under the revoked directions.

         19.    (1) This clause applies to an application to participate in the Program made under either the Pharmaceuticals Partnerships Program Directions No 1 of 2003 or the Pharmaceuticals Partnerships Program Directions No 1 of 2004 before those directions were revoked.

         (2) The Board must consider, in relation to applications that were made under subclause 19(1):

            (i) a request by the Delegate to provide a technical assessment of a proposal for approval of changes to the agreed portfolio of activities by a recipient; or

            (ii) a request by the Delegate to provide a technical assessment of the progress reported by a recipient against a technical milestone for the agreed portfolio of activities; or

            (iii) a request by the Delegate to provide a technical assessment as to whether a specific activity undertaken by a recipient is an eligible pharmaceutical R&D activity;

     as if the revoked directions under which the application was made continued to                             apply.

_______________________________________________________